Inactive Instrument

Press Releases Surgalign Holdings, Inc.

Equities

SRGA

US86882C2044

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

RTI Surgical Receives FDA IDE Approval for the Clinical Investigation of Cortiva Allograft Dermis in Breast Reconstruction	Nov. 28	AQ
Surgalign : RTI Surgical Receives FDA IDE Approval for the Clinical Investigation of Cortiva® Allograft Dermis in Breast Reconstruction	Nov. 26	PU
Surgalign : Bankruptcy - Form 8-K	23-09-29	PU
Surgalign Successfully Completes Auction and Names Successful Bidders For Asset Sales	23-07-28	GL
Surgalign Successfully Completes Auction and Names Successful Bidders For Asset Sales	23-07-28	AQ
SURGALIGN HOLDINGS, INC. : Regulation FD Disclosure (form 8-K)	23-06-23	AQ
Surgalign Receives NASDAQ Delisting Notice Following its Chapter 11 Filing	23-06-23	AQ
Surgalign Enters Into Definitive Agreement to Sell Global Hardware and Biologics Business Through a Structured Sale Process Under Chapter 11 of the U.S. Bankruptcy Code	23-06-20	AQ
Surgalign : Costs Associated with Exit/Disposal - Form 8-K	23-06-20	PU
Surgalign : Management Change/Compensation - Form 8-K	23-06-15	PU
Surgalign : Failure to Satisfy Listing Rule - Form 8-K	23-06-09	PU
Surgalign to Participate at ISASS 2023, 23rd Annual Conference Sponsored by the International Society for the Advancement of Spine Surgery and Medical Education Resources	23-05-24	AQ
Surgalign to Participate at ISASS 2023 – 23rd Annual Conference Sponsored by the International Society for the Advancement of Spine Surgery and Medical Education Resources	23-05-23	AQ
Surgalign: Q1 Earnings Snapshot	23-05-11	AQ
SURGALIGN HOLDINGS, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)	23-05-11	AQ
Surgalign Announces First Quarter 2023 Results and Provides Update on its Business Operations	23-05-11	AQ
Surgalign Announces Release of HOLO™ AI Insights for Neurovascular Research	23-05-08	AQ
Surgalign to Collaborate with Dr. Alexander Vaccaro and Dr. Pierce Nunley to Advance HOLO AI Insights and its Artificial Intelligence Technologies	23-05-04	AQ
Surgalign Schedules First Quarter 2023 Earnings Release for May 11, 2023	23-05-04	AQ
Surgalign To Collaborate with Dr. Alexander Vaccaro and Dr. Pierce Nunley to Advance HOLO™ AI Insights and its Artificial Intelligence Technologies	23-05-03	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Surgalign Holdings, Inc.

Equities

SRGA

US86882C2044

Press Releases

Filters